Overview

New Vital Pulpotomy Medications in Primary Molars

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2025-08-01
Target enrollment:
Participant gender:
Summary
Evaluate clinically and radiographically the effect of biodentine and hyaluronic acid (HA) versus formocresol (FC) as pulpotomy medications in primary molars.
Phase:
NA
Details
Lead Sponsor:
Mansoura University
Treatments:
formocresol
tricalcium silicate